How to reduce exposure when processing APIs

Global pharmaceutical company Cipla uses the Russell Compact Airlock Sieve as an integral part of its pharmaceutical process to screen APIs

When processing active pharmaceutical ingredients (API’s), the occupational exposure limit (OEL) has a significant part to play in the design of a process to ensure operators are not at risk to exposure.

With this in mind, Cipla Ltd, the global pharmaceutical company based in Mumbai, India, built its OEL-compliant plant at the Goa factory in 2005. For Cipla, having a screener that would ensure product quality and integrity were maintained without compromising the safety of their operators was essential.

In the search for a suitable screener to remove any oversized contamination from their incoming raw materials and to remove undersized particulates after granulation, Cipla attended an exhibition and came across the OEL level 5 compliant Russell Compact Airlock Sieve.

The sieve utilises a pneumatic clamping system that, combined with its patented Twist Lock Inflate (TLI) technology, provides a uniform dust tight seal.

Assembly and disassembly of the sieve is achieved in seconds. The component parts are placed into the base and located by twisting and locking the lid without the need for tools.

The airclamp is then inflated to secure and seal the unit during operation. The unit is suitable for either continuous or batch operations and also lends itself to applications where a number of different products are being processed due to the simplicity and speed with which it can be disassembled and cleaned.

Founded in 1934, Russell Finex has 85 years of expertise servicing the pharmaceutical industry with sieving and filtration solutions.

To speak with one of the company's specialists please contact Russell Finex today.

Companies